Penn's Hematology/Oncology Division is a comprehensive program dedicated to the clinical care and research, providing the most advanced treatment for all types of cancers and blood-related disorders. Our faculty members, more than 130, are involved in research to develop new and more effective methods for diagnosing and treating these diseases and for educating the physicians and researchers of the future. The division provides a framework in which basic scientists, translational researchers, clinical investigators and clinicians collaborate advance the understanding of difference cancers and blood disorders, and on designing new therapies. The synergy between basic and clinical research is a fundamental characteristic of the division.
Penn hematologists and medical oncologists are members of multidisciplinary teams. They approach the treatment of cancer and blood disorders by treating the entire individual; not just the disease. Patients benefit by having a team of experts from various specialties working together to determine the best course of treatment in a supportive, compassionate environment.
Our division spans three main clinical areas:
- Hematological Malignancies
- Solid Tumor Oncology
- Benign Hematology
World-Class Patient Care
Penn hematologists and medical oncologists specialize in the diagnosis, treatment and management of cancer and blood disorders. Hematologists and medical oncologists also coordinate overall patient care and direct chemotherapy and related medical treatments. The division’s clinical activities span 15 disease oriented areas and programs each of which focuses on a specific type of cancer or blood disorder. Our division sees approximately 198,000 outpatients per year and 135,000 visits for chemotherapy or immunotherapy infusions.
A Multidisciplinary Approach
Penn hematologists and medical oncologists work closely with other cancer specialists to provide patients with comprehensive, integrated care. They work side-by-side with other treatment team members including physicians and nurses who specialize in surgical oncology, radiation oncology, gynecologic oncology, urology, radiology and pathology to create a personalized medical treatment plan for every patient.
Penn hematologists/oncologists are also a part of Penn Medicine’s Abramson Cancer Center, a comprehensive cancer center designated as by the National Cancer Institute and rated "exceptional" during its most recent peer review.
Our hematologist and oncologist provide in patient care to cancer patients hospitalized at the Hospital of the University of Pennsylvania (HUP), Penn Presbyterian Medical Center, Pennsylvania Hospital and Chester County Hospital. For hospitalized patients, our physicians and nurse practitioners provide specialized care, also incorporating palliative care.
Satellite Locations and Physician Practices
The division operates or oversees multiple cancer and benign hematology programs in the region, extending the high quality care in the closer to home.
Comprehensive Educational Experiences
The Perelman School of Medicine at the University of Pennsylvania is ranked among the top in the country by U.S. News & World Report. High volume clinical services allow trainees to gain expertise with all types of cancers. Penn attracts residents and fellows with strong academic and leadership skills, giving trainees the opportunity to learn alongside some of the most talented and accomplished physicians, residents and fellows in the world. Penn's collaborative environment fosters productive interactions among fellow trainees and physicians from other disciplines and faculty. Graduates of Penn's residency and fellowship programs are highly recruited for leadership positions in academic medicine.
State-of-the-Art Research and Technology
Penn researchers in hematology/oncology participate in pioneering research ranging from fundamental cellular investigations to the latest, cutting-edge translational and clinical research. Patients benefit from research being done right here, right now at Penn Medicine.
- Penn's clinical and research programs are closely aligned with the National Institutes of Health (NIH) roadmap initiative emphasizing research that has a direct effect on patient outcomes.
- Penn Medicine has been awarded several highly competitive grants and selected to participate in a number of landmark clinical trials. Penn is the leading national site for several clinical trials.
- As one of the most stimulating academic environments in the world, new researchers at Penn can expect to collaborate and learn from some of the best minds in medicine in an interactive, highly networked and supportive working environment.
- Researchers at Penn Medicine have the opportunity to solve significant problems in their respective fields.
- Penn clinicians are pioneering the most advanced medical treatments, techniques and devices.